Genome instability footprint under rapamycin and hydroxyurea treatments.

"plos publication stage vor-update-to-uncorrected-proof publication update 2023-11-16 data availability the sequencing data of the mutation accumulation lines is available in the sra (sequence read archive) database under the bioproject id of prjna880975 ( https://www ncbi nlm nih gov/bioproject/?; data availability the sequencing data of the mutation accumulation lines is available in the sra (sequence read archive) database under the bioproject id of prjna880975 ( https://www ncbi nlm nih gov/bioproject/? the paper makes a significant contribution to the field and is a good fit for plos genetics ---------------------------------------------------- data deposition if you have submitted a research article or front matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as genbank or arrayexpress) one way to make that data available is to deposit it in the dryad digital repository .; journalid=pgenetics&manu=pgenetics-d-23-00878 more information about depositing data in dryad is available at http://www datadryad org/depositing . s1 table (xlsx data availability the sequencing data of the mutation accumulation lines is available in the sra (sequence read archive) database under the bioproject id of prjna880975"

"all the scripts are available on github ( https://github com/scan-o-matic/scanomatic ; last accessed september 1 2020)."

"The authors have declared that no competing interests exist."

"This work is supported by the National Natural Science Foundation of China (32000395 to JL and 32070592 to J-X Y), the Natural Science Foundation of Guangdong Province (2022A1515011873 to JL and 2022A1515010717 to J-X Y), the Guangdong Basic and Applied Basic Research Foundation (2019A1515110762 to J-X Y), the Guangdong Pearl River Talents Program (2021QN02Y168 to JL, 2019QN01Y183 to J-XY), Agence Nationale de la Recherche (ANR-15-IDEX-01), Fondation pour la Recherche Médicale (EQU202003010413), Association pour la Recherche sur le Cancer (ARCPJA32020070002320 to GL), and the Swedish Research Council (2018-03638 to JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."